MedTrace Logo

Intravenous Tranexamic Acid in Diabetic Macular TRD Surgeries

NCT06560073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2024-08-19

No results posted yet for this study

Summary

The goal of this observational study is to learn about safety and results of peroperative and intraoperative intravenous Tranexamic acid for diabetic macular tractional detachment eye surgeries . The main question it aims to answer is:

Adverse events and their frequency? immediate postoperative bleeding incidence? effective vitrectomy time?

Conditions

Sponsors & Collaborators

  • Ahalia Foundation Eye Hospital

    lead OTHER

Principal Investigators

  • RAJKUMAR MAHESHWARI, MS · Ahalia Foundation Eye Hospital

  • SAURAV MAHAJAN, MS · Ahalia Foundation Eye Hospital

  • AANCHAL MAINGI, DNB · AHALIA DIABETES HOSPITAL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2022-04-30
Completion
2022-10-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560073 on ClinicalTrials.gov